Arthneeti

Remus Pharmaceuticals Ltd vs Sun Pharmaceutical Industries Ltd

Side-by-side stock comparison based on AI earnings call analysis

Which stock has stronger management signals?

Remus Pharmaceuticals Ltd currently has the stronger revenue growth signal.

Remus Pharmaceuticals Ltd show active capex signals based on earnings call analysis.

No strong fundraising signal is currently visible for either company.

MetricRemus Pharmaceuticals LtdSun Pharmaceutical Industries Ltd
Current Price₹845₹1,935
Market Cap₹906.19 Cr.₹4.66 L Cr.
IndustryPharmaceuticals & BiotechnologyPharmaceuticals & Biotechnology
P/E Ratio24.536.92
ROE (%)12.1915.95
Debt/Equity0.080.06
Sales Growth 5Y (%)—11.78
Profit Growth 5Y (%)17.0514.45
Promoter Holding (%)70.9554.48
Revenue RankRank 2Rank 3
Margin RankRank 1Rank 3
Signal——
CapexYesNo information
FundraiseNo informationNo information
Analyze Remus Pharmaceuticals Ltd →Analyze Sun Pharmaceutical Industries Ltd →Compare other stocks →Stock Screener →